Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy
about
Macrophage Phenotype in Kidney Injury and RepairAutophagy, Innate Immunity and Tissue Repair in Acute Kidney InjuryRecent advances in understanding of chronic kidney diseaseParadigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now?Interferon-regulatory factors determine macrophage phenotype polarizationDendritic cells and macrophages in the kidney: a spectrum of good and evilMacrophage in chronic kidney diseaseRenal Arterial Disease and Hypertension.Both PD-1 ligands protect the kidney from ischemia reperfusion injury.Therapeutic translation in acute kidney injury: the epithelial/endothelial axisImproved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment.Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice.IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury.Acute kidney injury in 2014: a step towards understanding mechanisms of renal repair.Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injuryAn update on the role of the inflammasomes in the pathogenesis of kidney diseases.Optimizing Mouse Surgery with Online Rectal Temperature Monitoring and Preoperative Heat Supply. Effects on Post-Ischemic Acute Kidney InjuryHeme Oxygenase-1 Regulates Myeloid Cell Trafficking in AKIIL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease.Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injuryBiliverdin Reductase A (BVRA) Mediates Macrophage Expression of Interleukin-10 in Injured KidneyClinicopathological significance of CD206-positive macrophages in patients with acute tubulointerstitial disease.Heterogeneous susceptibility for uraemic media calcification and concomitant inflammation within the arterial tree.Renal artery stenosis: if and when to interveneElevated BP after AKI.Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)Regulated necrosis-related molecule mRNA expression in humans and mice and in murine acute tissue injury and systemic autoimmunity leading to progressive organ damage, and progressive fibrosis.NLRP3 Deficiency Attenuates Renal Fibrosis and Ameliorates Mitochondrial Dysfunction in a Mouse Unilateral Ureteral Obstruction Model of Chronic Kidney Disease.Interaction between systemic inflammation and renal tubular epithelial cells.Immune system modulation of kidney regeneration--mechanisms and implications.Immune cells in experimental acute kidney injury.Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD.Necroinflammation in Kidney Disease.HIF-1α induction during reperfusion avoids maladaptive repair after renal ischemia/reperfusion involving miR127-3p.Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.Tumor necrosis factor superfamily ligand mRNA expression profiles differ between humans and mice during homeostasis and between various murine kidney injuries.Macrophage dynamics in AKI to CKD progression.Myeloid Cell HO-ming in AKI.Gene expression profiling of the Notch-AhR-IL22 axis at homeostasis and in response to tissue injury.Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury.
P2860
Q26740474-0332B3A7-7522-4D7C-9DF2-26DC7EF39BFBQ26751502-6EFA5C48-136C-4119-A3FB-018518553028Q26827631-A1D8A3A7-56EE-49F5-86A7-046F3EBC0EBDQ26828388-1BC288DC-6F31-4FCE-8CC9-30B80598D627Q27012493-224F5FEE-1911-47B6-86C6-06526F5FDC35Q27023506-D692C82A-39B3-48C4-8D00-11680C02569EQ28068907-EBA9E19A-84A2-40E2-8625-4B5173B1D310Q30240722-57BFBDE1-DFC5-4573-B4CA-521DEB6BB627Q30301290-6D675060-160F-4A65-9347-B7C6D9F8FB5AQ30583254-754E98C6-E86A-4349-A14F-8DC742DD6E37Q33430882-57EB1C6C-3C47-4E92-ABED-55A7820B3D6FQ33891513-F0B45DE8-6798-4139-B5A9-788269C2BE2CQ35256069-BE955A60-6B20-471D-8EE2-7EDAC50992D0Q35550992-343B3459-9DF1-415B-8C57-37118F53997AQ35658602-06997966-24FA-48AE-B1B3-60715E8C8B7BQ35692937-CE83545A-874D-4BCD-909B-1A45D192DA24Q35927079-5421D972-0311-41D9-A445-821722846113Q36003153-02F47294-7DA9-4B5B-8D1C-82CF3E0DD5DCQ36040523-9F17A5A2-05A7-4E52-85E0-2C8938485C76Q36138680-6E0BA1E7-1B4D-44F6-B6AA-1E76A1397343Q36184272-C03ED036-BAD4-4A1E-9876-772C8017AA72Q36261805-DF30BCBF-21DF-42C0-9767-A866F430B8D3Q36307433-AD81FA16-B039-4851-A9D9-AF1B3CFD04FAQ36623565-6B51E5E0-952D-4E3B-86AF-D726A0BA8F3DQ36624663-7D6A100F-E773-4790-9C1B-30E90FA32463Q36817079-9171478D-C786-4EDE-B53A-67F91F107609Q37487744-A96AAF6C-A5A6-4BF7-AA14-1CCE2F0601B9Q37699992-CD6DC17E-0CBF-4175-B3C7-08EF592FBF61Q38192855-FAE70381-6A31-4808-A78F-265587FCB53AQ38207847-F4BB76F9-D6AA-44E1-BD4D-627E92553C17Q38261586-9332C934-CE6D-4F03-9545-FD14745D16BDQ38341214-89421449-2578-4F98-A79D-1EAC6BAB0DEFQ38579499-C4EF3A4A-8541-4BE9-B41E-9533B36B4529Q39010571-7A34A712-6AEA-4C9E-9689-C1C60E386A41Q40271425-A4A29E5E-118D-4D1B-9C2D-9B42A7C563D7Q41714457-06116621-2C86-462E-ACC8-F89F8066F7F3Q42732375-CD2EA071-1647-48E2-BE83-6A85B8F5CEC8Q42925818-4C6840D4-C1C7-48BC-90B0-3F03BF8692F8Q46278776-B3B5F08B-A7BC-4F1A-8DB1-955BE1AD1EBDQ47110302-6CAD33EE-445D-4EE8-B9AF-C523326A8D56
P2860
Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy
@en
Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy.
@nl
type
label
Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy
@en
Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy.
@nl
altLabel
Macrophage Phenotype Controls Long-Term AKI Outcomes—Kidney Regeneration versus Atrophy
@en
prefLabel
Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy
@en
Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy.
@nl
P2093
P2860
P356
P1476
Macrophage phenotype controls long-term AKI outcomes--kidney regeneration versus atrophy
@en
P2093
Georg Lorenz
Heni Eka Susanti
Ingo Hartter
Koichi S Kobayashi
Maciej Lech
Regina Gröbmayr
Richard A Flavell
Shrikant R Mulay
P2860
P304
P356
10.1681/ASN.2013020152
P577
2013-12-05T00:00:00Z